Provided by Tiger Trade Technology Pte. Ltd.

Replimune Group Inc.

13.42
+0.38002.91%
Post-market: 13.420.00000.00%19:30 EDT
Volume:2.02M
Turnover:26.81M
Market Cap:1.26B
PE:-4.25
High:13.44
Open:12.96
Low:12.79
Close:13.04
52wk High:16.33
52wk Low:1.50
Shares:94.22M
Float Shares:77.49M
Volume Ratio:1.05
T/O Rate:2.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1550
EPS(LYR):-3.3828
ROE:-134.29%
ROA:-51.30%
PB:11.97
PE(LYR):-3.97

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, SOLV Energy, Replimune

Reuters
·
May 29

Market Chatter: Replimune Plans to Resubmit Melanoma Therapy Application for FDA Approval

MT Newswires Live
·
May 29

Replimune Gets Third Try at FDA Approval After Makary Departure -- Update

Dow Jones
·
May 29

Replimune plans RP1 melanoma BLA resubmission after FDA talks

Reuters
·
May 29

Replimune reaches agreement with US FDA to resubmit melanoma drug application

Reuters
·
May 29

Replimune Announces Planned Rp1 Bla Resubmission Following Productive Discussion With FDA

THOMSON REUTERS
·
May 29

Replimune Group - to Resubmit Rp1 Bla for Advanced Melanoma After Alignment With FDA

THOMSON REUTERS
·
May 29

Replimune Group - to Resubmit Rp1 Bla; FDA to Prioritize Review as Urgent

THOMSON REUTERS
·
May 29

BRIEF-Replimune Gets Third Try At FDA Approval After Makary Departure- WSJ

Reuters
·
May 29

Replimune Gets Third TRY at FDA Approval After Makary Departure- WSJ

THOMSON REUTERS
·
May 29

Replimune Expected to Announce Agreement With FDA to Resubmit Its Advanced Melanoma Treatment for Approval - WSJ

THOMSON REUTERS
·
May 29

U.S. Earnings Preview: Before Market Open May 28

Dow Jones
·
May 28

Replimune Group call volume above normal and directionally bullish

TIPRANKS
·
May 21

Biotech Investors Are Tuning Out the MAHA Chaos -- Heard on the Street -- WSJ

Dow Jones
·
May 20

Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum looms

Reuters
·
May 14

BUZZ-U.S. STOCKS ON THE MOVE-Nebius, US chipmakers, Assertio Holdings

Reuters
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Tyler Technologies, Autodesk, Illumina

Reuters
·
May 13

BUZZ-Replimune, uniQure rise; FDA commissioner Makary plans to resign

Reuters
·
May 13

Trump says US FDA Commissioner Makary is out

Reuters
·
May 13

Replimune Group Shares Slip 2.9% Premarket After Nearly 22% Gain in Previous Session

THOMSON REUTERS
·
May 11